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Reply to Romoren
and Sundby
Sir—We appreciate the comments by Ro-
moren and Sundby [1] and their careful
reading of the article by Paz-Bailey et al.
[2] and our accompanying editorial [3].
In their comments, Drs. Romoren and
Sundby raise 3 issues.
First, they claim that our use of a dec-
imal point in calculating percentage de-
creases in prevalence between the 2 family
planning surveys is “simplifying and mis-
leading.” Although we would not use these
words and consider this issue to be a mat-
ter of style more than a matter of integrity
of data presentation, we understand their
point that to use a decimal point might
imply more precision than the underlying
data justify.
Second, the authors validly note the rel-
atively small sample sizes and potential
heterogeneity among the patients practic-
ing family planning who constituted the
study groups, data from which led to the
observed decreases in prevalences between
the 1993 and 2002 surveys. Fair enough.
But we would like to make 3 points. First,
we calculated percentage decreases only
for the patients practicing family planning
who participated in the Paz-Bailey study
precisely because we believed that, among
several varying populations in the article,
these were most likely to be homogeneous.
Second, we used the word “considerable”
to refer to these decreases and deliberately
avoided the word “significant” because of
the statistical implications this word can
have. Third, it is also potentially mislead-
ing for researchers to believe that differ-
ences with a P value of.05 are believable
and those with a value of 1.05 are not.
Although the 95% CIs for the trichomonas
prevalences quoted by Romoren and
Sundby do (marginally) overlap, we our-
selves would not interpret the differences
in prevalences much differently had they
not (marginally) overlapped.
Last, the authors indicate that we
should not be surprised that there were
decreases, given the “massive treatment
with multiple antibiotics for more than a
decade” for reproductive tract infections.
We appreciate this argument, which seems
to indicate support for our view that there
were, indeed, decreases. Although we agree
that this is likely a reason for the observed
decreases in prevalence, our editorial did
not ascribe such decreases solely to anti-
biotic use for treatment of reproductive
tract infections; rather, our editorial as-
cribed such decreases to multifaceted pro-
grams and interventions attempting to
diminish rates of sexually transmitted in-
fections, including messages to limit the
number of sex partners, encouragement
for condom use, and special, targeted in-
terventions for high risk populations. Sex-
ually transmitted pathogens, especially
bacterial ones, can be controlled when sus-
tained, consistent, standardized preven-
tion and treatment protocols are put in
place, as has been shown in a number of
developed and developing countries.
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Unusual Pathogens and
Multidrug-Resistant Bacteria
in Tsunami Survivors
Sir—We read with interest the article by
Hiransuthikul et al. [1] describing skin
and soft-tissue infections among tsunami
survivors. We were surprised by the very
low rate of multidrug-resistant pathogens
that were isolated.
During the tsunami, hundreds of for-
eign tourists were wounded. During the
following weeks, after they were stabilized
and given primary care, often in secondary
and tertiary care hospitals, survivors were
repatriated. We and others treated these
transferred patients, who were highly col-
onized and infected with multidrug-resis-
tant, gram-negative bacteria [2, 3].
The article by Hiransuthikul et al. [1]
could be misleading. Their results could
be interpreted to indicate that, in such a
situation, wounds were infected with easy-
to-treat bacteria. Environmental bacteria,
such as Acinetobacter or Pseudomonas spe-
cies, could present important antibiotic re-
sistance [4]. Tsunami survivors spent
hours or days in water and mold that were
at least partially contaminated with sew-
age. A large proportion of the multidrug-
resistant bacteria detected could have been
caused by nosocomial acquisition, mainly
in patients who were hospitalized for sev-
eral days [5]. Primary treatment and sta-
bilization were performed in very difficult
situations, where nosocomial acquisition
was likely to occur [6]. However, details
about previous hospitalizations are lacking
in the article. Furthermore, the description
of the isolates is insufficient. Data on an-
timicrobial susceptibilities are available
only for 78.7% of bacteria, but most
wounds presented polymicrobial infec-
tions. The article also has a high risk of
having been biased by the economical sit-
uation of the patients. Only patients
treated in private clinics are discussed, and
93% of those were foreign tourists. This
population is not representative of the lo-
cal victims.
In conclusion, we think that, in a similar
emergency situation, the presence of diffi-
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cult-to-treat, multidrug-resistant, gram-
negative bacteria should be assumed until
antimicrobial susceptibility tests are
available for 2 reasons: (1) to choose the
right empirical treatment and (2) to set
up a strict infection-control policy for the
prevention of the spread of imported
nosocomial infections [2, 3].
The article describes infections that
were detected some days after the tsunami;
we want to warn about atypical infections,
which are difficult to diagnose and treat,
that could appear after several weeks. Un-
usual pathogens should be suspected,
given the particular situation: very high
inocula, long exposure to the microorgan-
isms, and multiple broken barriers (e.g.,
wounds, near-drowning events, and frac-
tures). We and our colleagues recently
described 2 patients who developed un-
common infections, such as cutaneous
nocardiosis, atypical Mycobacterium spe-
cies soft tissue infection, Spedosporium
apiospermiun brain abscess, and spondy-
lodiskitis [2]. Several reports have de-
scribed other rare soft-tissue cutaneous
fungal infections [5, 7]. We should all be
aware that, in similar situations, a high
degree of suspicion should be maintained,
and a search for atypical pathogens should
be performed.
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Reply to Garbino
and Garzoni
Sir—In accordance with the letter by Gar-
bino and Garzoni [1], we agree that mul-
tidrug-resistant bacteria were not uncom-
mon as the causative pathogen of infected
wounds among tsunami survivors. How-
ever, we did find a large proportion of
tsunami survivors in southern Thailand
who had skin and soft-tissue infections
caused by relatively susceptible bacteria.
Our results were similar to data from local
hospitals in Phuket province. Among 47
patients with skin and soft-tissue infec-
tions whose pus or tissue samples were
cultured, 95 causative bacterial isolates
were found. The most common pathogens
were Klebsiella pneumoniae (23 cases),
Escherichia coli (18 cases), Proteus species
(15 cases), and Aeromonas species (13
cases). More than 90% of these organisms
(except for Aeromonas species, for which
antimicrobial susceptibility was not tested)
were susceptible to cefuroxime, ceftriax-
one, imipenem, ciprofloxacin, netilmicin,
and gentamicin. However, only 38%–60%
of E. coli and Proteus species were suscep-
tible to amoxicillin–clavulinic acid (un-
published data). We think that the fre-
quency of multidrug-resistant bacteria was
dependent on the duration of time from
injury to culture, particularly among hos-
pitalized patients. The longer the duration,
the more-frequently multidrug-resistant,
hospital-acquired bacteria were found. In
our study, the mean duration from injury
until specimens were sent for culture
(which was similar to that for the local
hospital) was 3 days. This was probably
because most patients were foreigners, and
they were rapidly transferred from local
hospitals to Bangkok and, subsequently, to
their home countries, so we had relatively
few patients with a longer hospital stay.
This probably accounts for the relatively
few multidrug-resistant, hospital-acquired
bacteria found.
We accept that our study might have
had some selection bias and limited gen-
eralization, because the subjects enrolled
in private hospitals in Bangkok were
mostly foreigners and might not have been
representative of local victims. However,
the selection of patients from private hos-
pitals instead of local hospitals allowed us
to enroll more patients in the study whose
clinical specimens were sent for culture,
which resulted in more-accurate bacterial
isolation and antimicrobial susceptibility
testing. The local hospitals, which had
huge casualties after the disaster, had lim-
ited facilities for proper specimen collec-
tion and testing, and they usually admin-
istered empirical antibiotic therapy
without culture. Finally, because most tsu-
nami victims who were foreigners were
usually transferred to their home countries
soon after the disaster, organisms with a
long incubation period that cause invasive
infection, such as fungi, might have not
been detected in our study. Therefore, we
think that our results are not misleading,
but the decision to select appropriate em-
pirical antimicrobial treatment should be
based on the circumstances in which the
injuries occur, including the duration
from injury to culture and the clinical set-
ting of patients (community- vs. hospital-
acquired infection). If possible, the nar-
rowest spectrum antibiotics should be
used for treatment [2].
